Tag Archives: codeine

Downside of codeine upscheduling hailed

The TGA’s upscheduling of codeine has produced a welcome downside, with researchers describing “a massive and abrupt reduction in codeine poisonings”, and data revealing codeine sales have halved. This week, researchers from the University of Sydney published the first peer-reviewed research to examine the short-term implications of the February 2018 …

Read More »

Real-time prescription monitoring a step closer

Real-time prescription monitoring is one step closer following the Queensland parliament’s passing of the Medicines and Poisons Act and the Therapeutic Goods Act this week. Queensland Minister for Health and Ambulance Services, Steven Miles, said once introduced, the monitored medicines database would provide life-saving benefits by assisting doctors when prescribing …

Read More »

Financial results for Aussie pharma companies

Sigma Healthcare While overall revenue is up by 6.9 per cent, Sigma Healthcare has suffered a significant drop in profit, as restructuring costs relating to the end of My Chemist/Chemist Warehouse contract begin to bite. The company released financial results for the six months to July 31 2019, showing Net …

Read More »

SafeScript already saving lives

SafeScript is already saving lives and keeping patients with prescription medication addictions safe from harm. In its first two months, SafeScript has alerted doctors and pharmacists in western Victoria to almost 3,300 patients at risk of harm or overdose from visiting multiple clinics or pharmacies. Deaths caused by prescription medicine …

Read More »

Government support for codeine transition

The industry has welcomed the federal government’s funding support for pharmacists through the transition of up-scheduling pain-relief medicines containing codeine from February 2018. Federal Health Minister Greg Hunt has confirmed to the Pharmacy Guild and the Pharmaceutical Society of Australiathat the government will provide funding for training of pharmacists and …

Read More »